Loading...
Immunotherapy updates in pancreatic cancer: are we there yet?
Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional therapies. Historically, chemotherapy or radiotherapy did not provide meaningful survival benefit in advanced pancreatic cancer. Gemcitabine and recently FOLFIRINOX (5-flourouracil, leucovorin, oxalipl...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539275/ https://ncbi.nlm.nih.gov/pubmed/23323149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012462463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|